RE.DOCTOR LLC Achieves ISO 13485 Certification, Underscoring Commitment to Quality and Patient Safety in Medical Device Development
ISO 13485 certification will allow them to expand their reach and bring their innovative medical devices to a wider range of patients around the world. - March 12, 2024
RE.DOCTOR introduces the Vital Signs Monitor: Collecting Physiologic Data for Health and Life Insurance Risk Assessment
By measuring indicators such as heart rate, blood pressure, respiratory rate and temperature, insurers gain valuable insights into policyholder health and wellness over time. - December 18, 2023
RE.DOCTOR Enters Digital Therapeutics Market with Blood Glucose App
Digital Therapeutics company RE.DOCTOR announces first in line of chronic disease screening apps. - May 09, 2023
RE.DOCTOR Releases Non-Invasive Smartphone Vital Signs Screening
Easy to add non-invasive smartphone vitals, blood glucose, and body scan tools to your existing health or medical app, and have vital sign data delivered to your EMR or healthcare platform. - May 03, 2023
RE.DOCTOR Releases Non-Invasive Blood Glucose Monitoring
RE.DOCTOR, through its development of Non-Invasive Blood Glucose Monitoring (BGM), has engineered a pre-diabetes solution that is non-invasive, easily accessible, and low cost. The latest Singapore National Population Health Survey shows that diabetes, and its related outcomes, are expected to be... - December 27, 2022
RE.DOCTOR Releases Smartphone Camera to Extract Vital Signs
With RE.DOCTOR, patients can use their smartphone camera to extract vital sign transdermal physiological parameters in a matter of seconds. The RE.DOCTOR AI-based vital sign scanner uses world leading AI technology and works on any device with an embedded camera. Accurate blood pressure, pulse,... - December 27, 2022